Research Paper Volume 16, Issue 7 pp 6163—6187
KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer
Figure 1. Expression levels of KIF3C in different tissues in pan-cancer. (A) Expression levels of KIF3C in tumor and paired adjacent noncancerous tissues from TCGA. (B) KIF3C expression difference in 33 tumors integrating data of normal tissues in GTEx database and tumor tissues in TCGA database. (C) KIF3C expression in immune cells in STAD via the TISCH database. *p < 0.05, **p < 0.01, ***p < 0.001, ns p ≥ 0.05.